L-type calcium channel gating and modulation in normal and failure states
正常和故障状态下的 L 型钙通道门控和调节
基本信息
- 批准号:6575126
- 负责人:
- 金额:$ 20.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-01-01 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Functional hallmarks of heart failure include prolonged action-potential duration, depressed contraction and intracellular Ca2+ transients, as well as blunted adrenergic responsiveness. Among the molecules implicated as underlying players, the L-type channel is particularly important. For example, in cells isolated from dogs with pacing-induced heart failure (HF cells), a key factor underlying action potential prolongation appears to be decreased L-type channel inactivation. However, rigorous assessment of the role of L-type channels in heart failure is hampered by crucial gaps in understanding inactivation and functional modulation by auxiliary channel subunits. The overall goal is to deepen fundamental understanding of L-type channels in these gap areas, and to bridge the enhance basic knowledge to a new appreciation of how these channels contribute to heart failure. Using HF cells from dogs and humans, we will pursue the following 5 Aims, each targeting a salient gap in understanding channel performance during failure. 1. To clarify fundamental uncertainties about voltage-dependent inactivation of cardiac L-type channels. 2. To discover structure-based mechanisms of Ca2+- dependent inactivation of cardiac L-type channels. 3. To determine the potential for tuning L-type channel function and expression by Ca channel beta subunits. 4. To identify the profile of Ca channel beta subunits in normal and failing dog and human heart tissue. 5. To establish a functional profile of L-type channel properties in HF cells., and to test whether expression of recombinant beta subunits can alter or "normalize" identified irregularities in function. The latter experiments will help lay the groundwork for gene therapy of excitability disorders and heart failure.
心力衰竭的功能特征包括动作电位持续时间延长、收缩和细胞内Ca2+瞬变抑制以及肾上腺素能反应性减弱。在作为潜在参与者的分子中,L型通道特别重要。例如,在从患有起搏诱导的心力衰竭的狗中分离的细胞(HF细胞)中,动作电位延长的关键因素似乎是降低的L型通道失活。然而,严格评估L型通道在心力衰竭中的作用受到理解辅助通道亚基失活和功能调节的关键差距的阻碍。总体目标是加深对这些空白区域中L型通道的基本理解,并将增强基础知识与对这些通道如何导致心力衰竭的新认识联系起来。使用来自狗和人类的HF细胞,我们将追求以下5个目标,每个目标都针对理解故障期间通道性能的显著差距。1.阐明心脏L型通道电压依赖性失活的基本不确定性。2.发现心脏L型通道钙依赖性失活的结构机制。3.确定钙通道β亚基调节L型通道功能和表达的潜力。4.确定正常和衰竭犬和人心脏组织中钙通道β亚基的分布。5.建立HF细胞中L型通道特性的功能谱,并测试重组β亚基的表达是否可以改变或“正常化”鉴定的功能不规则性。后者的实验将有助于为兴奋性障碍和心力衰竭的基因治疗奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID T YUE其他文献
DAVID T YUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID T YUE', 18)}}的其他基金
Chemical biological dissection of Ca2+ entry through Ca2+ channels
Ca2+通过Ca2+通道进入的化学生物学解剖
- 批准号:
8609908 - 财政年份:2013
- 资助金额:
$ 20.97万 - 项目类别:
相似海外基金
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Arrhythmia Mechanisms Modulated by Intercalated Disc Extracellular Nanodomains
闰盘细胞外纳米结构域调节心律失常的机制
- 批准号:
10668025 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Development of a next-generation telemonitoring system for prognostic prediction of the onset of heart failure and arrhythmia
开发下一代远程监测系统,用于心力衰竭和心律失常发作的预后预测
- 批准号:
23K09597 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of inflammation in the pathogenesis of atrial fibrillation: Implications for atrial remodeling pathophysiology and for early atrial arrhythmia recurrences following radiofrequency ablation and pulsed field ablation
炎症在心房颤动发病机制中的作用:对心房重塑病理生理学以及射频消融和脉冲场消融后早期房性心律失常复发的影响
- 批准号:
514892030 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
WBP Fellowship
Improved arrhythmia ablation via MR-guided robotic catheterization and multimodal clinician feedback
通过 MR 引导的机器人导管插入术和多模式临床医生反馈改善心律失常消融
- 批准号:
10638497 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Prototype development and validation of soft robotic sensor arrays for mapping cardiac arrhythmia
用于绘制心律失常的软机器人传感器阵列的原型开发和验证
- 批准号:
10722857 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
A novel regulator of Ca2+ homeostasis and arrhythmia susceptibility
Ca2 稳态和心律失常易感性的新型调节剂
- 批准号:
10724935 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
Novel Stellate Ganglia Chemo-ablation Approach to Treat Cardiac Arrhythmia and Cardiac Remodeling in Heart Failure
新型星状神经节化疗消融方法治疗心律失常和心力衰竭心脏重塑
- 批准号:
10727929 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
- 批准号:
10733915 - 财政年份:2023
- 资助金额:
$ 20.97万 - 项目类别: